Summary Fibroblast growth factors (FGFs) and fibroblast growth factor receptors (FGFRs) have been increasingly recognized to play an important role in the pathobiology of pancreatic malignancy. We have investigated the effects of FGF-1 and FGF-2 on the behaviour and adhesion properties of human pancreatic adenocarcinoma cell lines (BxPc3, T3M4 and HPAF) that were previously characterised for the expression of FGFRs. Here we show that exposure to FGF-1 and FGF-2 leads to significant and dose-dependent increase in E-cadherindependent cell-cell adhesion, tubular differentiation, and a reduced capacity to invade collagen gels. FGF stimulation produces phosphorylation of E-cadherin and β-catenin on tyrosine residues, as well as increased E-cadherin localisation to the cytoplasmic membrane and association with FGFR1 demonstrable by coimmunoprecipitation. These results demonstrate that FGF-1 and FGF-2 may be involved in the regulation of cell adhesion, differentiation and invasion of pancreatic cancer. © Cancer Research Campaign http://www.bjcancer.com
Growth factors and antibodiesHuman recombinant FGF-1 and FGF-2 (Upstate Biotechnology, Lake Placid, NY, USA) were used for stimulation of the cell lines at various concentrations between 1 ng/ml and 50 ng/ml. Heparin was added at 10 µg/ml and 1 µg/ml with FGF-1 and FGF-2, respectively, as shown to be suitable for FGFR activation by FGFs in this tissue type (Leung et al, 1994).The mouse monoclonal anti-human E-cadherin antibody, HECD-1, was kindly provided by Prof. Takeichi (Kyoto University, Kyoto, Japan). Mouse monoclonal anti-human E-cadherin, α-, β-and γ-catenin antibodies were purchased from Transduction Laboratories, Exeter, UK. The monoclonal anti-Ep-CAM (AUA-1) and anti-CEA (PR3B10) antibodies were kindly provided by Sir Walter Bodmer (ICRF). The anti-FGFR antibodies used in the study were anti-FGFR-1 antibodies (8E10 (Prizm Pharmaceuticals) and VBS6 (Santa Cruz)). Anti-phosphotyrosine antibody 4G10 was purchased from Upstate Biotechnology.
Cell-cell adhesion assayCells were grown to 90% confluence, washed twice in PBS, and subsequently treated with 2 mM EDTA for 10 min at 37˚C. Detached cells were washed once with RPMI medium and were passed through Pasteur pipettes several times to obtain single cells. Cells were then re-suspended in either Ca 2+ -free PBS/0.8% FCS or RPMI/0.8% FCS (controls). In FGF stimulation experiments, FGF-1 or FGF-2 was added to the medium at concentrations of 1, 5, 10, 20, and 50ng/ml at the time of initiation of the assay. Cells were then inoculated at 5×10 5 cells/ml into 24-well plates (500µl/well) that had been coated overnight with 1% (w/v) bovine serum albumin in PBS to prevent non-specific cell adhesion to wells. Cells were allowed to aggregate for 1 h at 37˚C on a gyratory shaker with constant rotation at 90 rpm. Cell aggregation was terminated by the addition of 4% (w/v) glutaraldehyde fixative to individual wells at 0, 15, 30, 45 or 60 min. Aliquots were taken at each time point and the number of single cells was then determin...